8-K/A

8-K/A ALEXION MARCH 2017

Company: Arbutus Biopharma Corp
Filed: March 20, 2017
Period of Report: March 20, 2017
Accession Number: 0001628280-17-002711

View Document ↗ View on SEC.gov ↗